Outcome
| Type |
Measure |
Description |
Time frame |
Safety issue |
| Primary |
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen |
Each patient will receive a quantitative symptom assessment survey (Edmonton Symptom Assessment Scale). The scale is a 10-point scale measured from 0 to 10 where 0 represents no symptom and 10 represents the worse severity of the symptom. The scale measures 10 symptoms. |
Baseline (at time of patient enrollment) |
|
| Primary |
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen |
Each patient will receive a quantitative symptom assessment survey (Edmonton Symptom Assessment Scale) at 6 months. The scale is a 10-point scale measured from 0 to 10 where 0 represents no symptom and 10 represents the worse severity of the symptom. The scale measures 10 symptoms. |
6 months after patient enrollment |
|
| Primary |
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen |
Each patient will receive a quantitative symptom assessment survey (Edmonton Symptom Assessment Scale) at 12 months. The scale is a 10-point scale measured from 0 to 10 where 0 represents no symptom and 10 represents the worse severity of the symptom. The scale measures 10 symptoms. |
12 months after patient enrollment |
|
| Primary |
Personal Health Questionnaire-9 (PHQ-9) Depression Screen |
Each patient will receive a Personal Health Questionnaire-9 (PHQ-9) at baseline. PHQ-9 is measured on a scale of 0-27, where scores of 5, 10, 15, and 20 are cut-points for mild, moderate, moderately severe and severe depression, respectively. |
Baseline (at time of patient enrollment) |
|
| Primary |
Personal Health Questionnaire-9 (PHQ-9) Depression Screen |
Each patient will receive a Personal Health Questionnaire-9 (PHQ-9) at 6 months. PHQ-9 is measured on a scale of 0-27, where scores of 5, 10, 15, and 20 are cut-points for mild, moderate, moderately severe and severe depression, respectively. |
6 months after patient enrollment |
|
| Primary |
Personal Health Questionnaire-9 (PHQ-9) Depression Screen |
Each patient will receive a Personal Health Questionnaire-9 (PHQ-9) at 12 months. PHQ-9 is measured on a scale of 0-27, where scores of 5, 10, 15, and 20 are cut-points for mild, moderate, moderately severe and severe depression, respectively. |
12 months after patient enrollment |
|
| Secondary |
% of patients with Emergency Department Visit within 12-months after patient enrollment (Chart Review) |
Emergency Department use for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment. We will evaluate comparisons of the % of patients with emergency department visits between study arms. |
12 months after patient enrollment |
|
| Secondary |
% of patients with Hospitalization Visits within 12 months after patient enrollment (Chart Review) |
Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment. We will evaluate comparisons of hospitalizations between the two study arms. |
12 months after patient enrollment |
|
| Secondary |
% of patients with a Hospice Consult within 12-months after patient enrollment (Chart Review) |
Hospice consult for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment. |
12 months after patient enrollment |
|
| Secondary |
Total Health Care Costs (Claims Review) |
Total Health Care Costs for each patient will be abstracted by medical claims data review for each patient at 12 months after enrollment. |
12 months after patient enrollment |
|
| Secondary |
% of patients with an Acute Care Facility Death (Chart Review) |
Acute Care Facility Deaths for each patient will be abstracted by electronic medical record chart review and claims review for each patient who has died at 12-months followup. We will evaluate comparisons of Acute Care Facility Deaths between study arms. |
30 days prior to death for patients who died at 12-months follow-up |
|
| Secondary |
% of patients with Emergency Department Visit in the last 30 days of life (Chart Review) |
Emergency Department use for each patient will be abstracted by electronic medical record chart review for each patient who has died. We will evaluate comparisons of emergency department visits between study arms. |
30 days prior to death for patients who died at 12-months follow-up |
|
| Secondary |
% of patients with Hospitalization Visits in the last 30 days of life (Chart Review) |
Hospital use for each patient will be abstracted by electronic medical record chart review for each patient who has died. We will evaluate comparisons of hospitalization use between study arms. |
30 days prior to death for patients who died at 12-months follow-up |
|
| Secondary |
% of patients with a Hospice Consult in the last 30 days of life (Chart Review) |
Hospice use for each patient will be abstracted by electronic medical record chart review for each patient who has died. We will evaluate comparisons of hospice use between study arms. |
30 days prior to death for patients who died at 12-months follow-up |
|
| Secondary |
Total Costs of Care (Claims Review) |
Total costs of care for each patient will be obtained through claims data for each patient for each patient who has died. We will evaluate comparisons of Total costs of care between study arms. |
30 days prior to death for patients who died at 12-months follow-up |
|
